iAnthus Capital HoldingsFRA:2IA Days Inventory is 120.68 as of Mar. 2026, which is 14% above its 10-year median of 105.96. The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, iAnthus Capital Holdings ranks better than 77.12% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
iAnthus Capital Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.76.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
iAnthus Capital Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.69.
iAnthus Capital Holdings (FRA:2IA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
iAnthus Capital Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
iAnthus Capital Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
iAnthus Capital Holdings Days Inventory Related Terms
iAnthus Capital Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iAnthus Capital Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where iAnthus Capital Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iAnthus Capital Holdings (FRA:2IA) has a Days Inventory of 120.68 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on iAnthus Capital Holdings and its competitors. This is 14% above median its historical median of 105.96. Over the past decade, iAnthus Capital Holdings' Days Inventory has ranged from 91.53 to 128.58. According to the industry distribution chart, iAnthus Capital Holdings ranks #210 out of 918 companies in the Drug Manufacturers industry, placing it in the top 22.9%.
Is iAnthus Capital Holdings' Days Inventory too high?
iAnthus Capital Holdings' current Days Inventory of 120.68 is 14% above median its 10-year median of 105.96. Over the past 10 years, this metric has ranged from a low of 91.53 to a high of 128.58. The Drug Manufacturers industry median Days Inventory is 164.43. iAnthus Capital Holdings' value of 120.68 is 26.6% below this industry median. Based on the distribution chart, iAnthus Capital Holdings ranks #210 out of 918 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does iAnthus Capital Holdings' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, iAnthus Capital Holdings ranks #210 out of 918 companies for Days Inventory. This places iAnthus Capital Holdings in the top 23% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.43. iAnthus Capital Holdings' value of 120.68 is 26.6% below this benchmark. Historically, iAnthus Capital Holdings' own Days Inventory has ranged from 91.53 to 128.58 over the past decade. While the company's 10-year median is 105.96 vs. the industry median of 164.43, iAnthus Capital Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iAnthus Capital Holdings's current Days Inventory of 120.68 is 26.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on iAnthus Capital Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iAnthus Capital Holdings's current Days Inventory is 120.68, which is 14% above median its own 10-year median of 105.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current Days Inventory of 120.68. The current Days Inventory is 120.68, which is 14% above median its 10-year median of 105.96 and 26.6% below the Drug Manufacturers industry median of 164.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current Days Inventory is 120.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2IA has been successfully added to your 